|
Raxar
Raxar is an antibiotic that was approved for use by the Federal Drug Administration
in November 1997. This approval came despite indications that the drug could
cause serious heart rhythm disturbances. In fact, clinical trials under review
by the FDA suggested that at least two deaths occurred as a result of heart
rhythm disturbances. Yet, the FDA chose not to require a warning on the drug
packaging and Glaxo, the manufacturer of Raxar also opted to keep these suspicions
undisclosed. Instead, Glaxo merely indicated on Raxar labels that "there were
no deaths or permanent disabilities" among those who took the drug in 400-milligram
doses. That statement was true. However, patients who died in the clinical study
took 600-milligram doses of Raxar. According to records filed with the FDA,
Raxar has been cited as a suspect in 13 reported deaths.
If you or a loved one is in need of legal assistance, call Gonzalez & Garcia Toll Free at (800) 352-HURT or submit
an online questionnaire. The initial consultation is free of charge, and
if we agree to handle your case, we will work on a contingency fee basis, which
means we get paid for our services only if there is a monetary recovery of funds.
In many cases, a lawsuit must be filed before an applicable expiration date,
known as a statute of limitations. Please call right away to ensure that you
do not waive your right to possible compensation.
© Copyright 2008 – Gonzalez & Garcia, MegaHunter Inc. and Attorney Hunter, an
Attorney Directory-Lawyers, Law Firms, Attorneys. Lawyer Websites – Attorney Websites – Law
Firm Websites – Legal Websites designed by
MegaHunter, Inc. All Rights Reserved. |